Pulmatrix Free Cash Flow (FCF) History (PULM)

Pulmatrix reported −$11.1M in free cash flow for fiscal 2024, an increase of $5.5M from the previous fiscal year, with a free cash flow margin of −142.38%.

View full Pulmatrix company overview

Pulmatrix free cash flow by year

Pulmatrix annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20242024-12-31−$11.1M$5.5M−142.38%
20232023-12-31−$16.7M$2.8M−228.30%
20222022-12-31−$19.4M$429,000−320.24%
20212021-12-31−$19.9M−$7.1M−384.43%
20202020-12-31−$12.8M−$15.9M−101.03%
20192019-12-31$3.2M$20.0M+40.10%
20182018-12-31−$16.8M−$2.2M−10967.32%
20172017-12-31−$14.6M−$853,000−4343.58%
20162016-12-31−$13.7M−$960,000−1640.48%
2015 · Dec 312015-12-31−$12.7M−$7.2M−1060.62%
2015 · Mar 312015-03-31−$5.5M$3.9M
2014 · Dec 312014-12-31−$9.5M−$6.5M−2684.94%
2014 · Mar 312014-03-31−$3.0M

Pulmatrix free cash flow growth trends

Over the last five reported fiscal years, free cash flow declined from $3.2M to −$11.1M, a net decrease of $14.3M. Pulmatrix's latest reported quarter, Q4 2024, generated −$1.3M in free cash flow, an increase of $3.2M year over year.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review Pulmatrix filings at SEC.gov ↗